DRRX: Summary for Durect Corporation - Yahoo! Singapore Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, November 25, 2009, 12:41am SGT - The Singapore stock market opens in 8 hours and 19 minutes.

To create a watchlist or portfolio of shares, Register

FINANCE HOME PAGE

INVESTING

FINANCE NEWS

Durect Corp. (DRRX)

At 12:25AM SGT: 2.21 USD 0.00 (0.00%)

MORE ON DRRX

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Durect Corporation (NGM:DRRX) Delayed quote data

Last Trade:	2.21 USD
Trade Time:	12:25AM SGT
Change:	0.00 (0.00%)
Prev Close:	2.21
Open:	2.22
Bid:	2.20 x 100
Ask:	2.21 x 300
1y Target Est:	4.13

Day's Range:	2.19 - 2.24
52wk Range:	1.40 - 4.26
Volume:	14,812
Avg Vol (3m):	276,620
Market Cap:	191.71M
P/E (ttm):	N/A
EPS (ttm):	-0.49
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Use Y! Toolbar to track stocks

Add DRRX to Portfolio

Download Data

HEADLINES

•	DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference
	PR Newswire (Tue 5:15am)

•	DURECT CORP Financials
	EDGAR Online Financials (Fri, Nov 6)

•	DURECT CORP Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Tue, Nov 3)

•	DURECT Corporation Earnings Call scheduled for 4:30 pm ET today
	CCBN (Fri, Oct 30)

•	DURECT CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
	EDGAR Online (Fri, Oct 30)

•	DURECT Corporation Announces Third Quarter 2009 Financial Results
	PR Newswire (Fri, Oct 30)

•	Q3 2009 DURECT Corporation Earnings Release - After Market Close
	CCBN (Thu, Oct 29)

•	DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call
	PR Newswire (Tue, Oct 27)

•	5 Top Stocks at Half Price
	at Motley Fool (Tue, Sep 29)

•	DURECT Corporation to Participate in Upcoming Healthcare Conferences
	PR Newswire (Thu, Sep 17)

More Headlines for DRRX...

ANALYST

EPS Est (next year) (Dec-09) :	-0.34
EPS Est (in 2 years) (Dec-10) :	-0.29
Avg Rec (current)*:	1.3
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

DURECT Corporation, a specialty pharmaceutical company, focuses on the development of pharmaceutical products for pain, central nervous system, disorders, cardiovascular disease, and other chronic diseases based on its proprietary drug formulation...

Full Company Profile

Add to Portfolio

Email to a Friend

•